Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 996-1001

  Laverman, Peter ^a   Brouwers, Adrienne H ^a   Dams, Els Th M ^a   Oyen, Wim J G ^a   Storm, Gert ^b   Van Rooijen, Nico ^c   Corstens, Frans H M ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; LIPOSOME TC 99M; MACROGOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CLINICAL TRIAL; DOSE RESPONSE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; ENTEROBACTER INFECTION; FEMALE; HUMAN; ISOTOPE LABELING; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPOSOMES; MACROPHAGES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RABBITS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0034047673     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abrams MJ, Juweid M, ten Kate CI, Schwartz DA, Hauser MH, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW and Fischman AJ (1991) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection. J Nucl Med 31:2022-2028.
2. Allen TM and Chonn A (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 223:42-46.
3. Allen TM and Hansen C (1991) Pharmacokinetics of stealth versus conventional liposomes: Effect of dose. Biochim Biophys Acta 1068:133-141.
4. Beaumier PL, Hwang KJ and Slattery JT (1983) Effect of liposome dose on elimination of small unilamellar sphigomyelin/cholesterol vesicles from the circulation. Res Commun Chem Pathol Pharmacol 39:277-289.
5. Boerman OC, Oyen WJG, Storm G, Corvo ML, van Bloois L, van der Meer JWM and Corstens FHM (1997) Technetium-99m labeled liposomes to image experimental arthritis. Ann Rheum Dis 56:369-373.
6. Claessens RAMJ, Boerman OC, Koenders EB, Oyen WJG, van der Meer JWM and Corstens FHM (1996) Technetium-99m labelled hydrazinonicotinamido human nonspecific polyclonal immunoglobulin G for detection of infectious foci: A comparison with two other technetium labelled imunnoglobulin preparations. Eur J Nucl Med 23:414-421.
7. Dams ETM, Nijhof MW, Boerman OC, Laverman P, Storm G, Buma P, Lemmens JAM, van der Meer JWM, Corstens FHM and Oyen WJG (1999) Scintigraphic evaluation of experimental chronic osteomyelitis. J Nucl Med, in press.
8. Dams ETM, Oyen WJG, Boerman OC, Storm G, Laverman P, Koenders EB, van der Meer JWM and Corstens FHM (1998) Tc-99m-labeled liposomes to image experimental colitis in rabbits: Comparison with Tc-99m-HMPAO-granulocytes and Tc-99m-HYNIC-IgG. J Nucl Med 39:2172-2178.
9. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: Clinical evaluation. J Nucl Med 41:622-630.
10. Gabizon A and Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake in tumors. Proc Natl Acad Sci USA 85:6949-6953.
11. Gregoriadis G, Putman D, Louis L and Neerunjun D (1974) Comparative effect and fate of nonentrapped and liposome-entrapped neuraminidase injected into rats. Biochem J 140:323-331.
12. Juliano R and Stamp D (1975) The effect of particle size and charge on the clearance rates of liposomes and liposome-encapsulated drugs. Biochem Biophys Res Commun 63:651-658.
13. Kozma C, Macklin W, Cummins LM and Mauer R (1974) Anatomy, physiology, and biochemistry of the rabbit, in The Biology of the Laboratory Rabbit (Weisbroth SH, Flatt RE and Kraus AL eds) pp 49-72, Academic Press, New York.
14. Laverman P, Dams ETM, Oyen WJG, Storm G, Koenders EB, Prevost R, van der Meer JWM, Corstens FHM and Boerman OC (1999) A novel method to label liposomes with Tc-99m by the hydrazino nicotinyl derivative. J Nucl Med 40:192-197.
15. Liu D, Hu Q and Song YK (1995) Liposome clearance from blood: Different animal species have different mechanisms. Biochim Biophys Acta 1240:277-284.
16. Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A and Iwatsuru M (1992) Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1128:44-49.
17. Oja CD, Semple SC, Chonn A and Cullis PR (1996) Influence of dose on liposome clearance: Critical role of blood proteins, Biochim Biophys Acta 1281:31-37.
18. Rouser G, Fleischer S and Yamamoto A (1970) A two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496.
19. Utkhede DR and Tilcock CP (1998) Effect of lipid dose on the biodistribution and blood pool clearance kinetics of PEG-modified technetium-labeled lipid vesicles. J Liposome Res 8:381-390.
20. Van Rooijen N and Sanders A (1994) Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 174:83-93.
21. Woodle MC and Lasic DD (1992) Sterically stabilized liposomes. Biochim Biophys Acta 1113:171-190.
22. Zysk G, Bruck W, Huitinga I, Fischer FR, Flachsbarth F, van Rooijen N and Nau R (1997) Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol 73:77-80.